Sign in
4

Changes in Ownership

Processa Pharmaceuticals, Inc. Filed Acc 0000897069-26-000756

Pres. Research & Development bought 1,810 shares at $2.54 ($4,588)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Young David Pres. Research & Development 2026-03-31 Purchase +1,810 $2.54 $4,588 10,562 D
Open-market purchases · 1,810 sh · avg $2.54 · $4,588
Loading xslF345X06/form4.xml…